---
title: "Based on current experimental data, the targets of the three pipelines are relatively clear and… — 昂利康 — DecisionGateway"
description: "statement by 昂利康, recorded recently — verbatim quote and source citation."
canonical_url: "https://dgw.tmarket.io/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512"
meta:
  "og:description": "statement by 昂利康, recorded recently — verbatim quote and source citation."
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "Based on current experimental data, the targets of the three pipelines are relatively clear and… — 昂利康 — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

statement

# **Based on current experimental data, the targets of the three pipelines are relatively clear and have a certain probability of becoming drugs.**

A statement by [**昂利康**](https://dgw.tmarket.io/actors/01a1e5e4-6301-768b-9dc5-723154c5f34d). Statements are as reported by the cited publishers — not verified by DecisionGateway.

> *從目前的實驗數據來看，三條管線靶點相對明確，具備一定成藥的概率*

stockintelligencenewsPublished 2026-11-11 [ Read source](https://t.me/stockintelligencenews/5715383)

[**昂利康 dossier **](https://dgw.tmarket.io/actors/01a1e5e4-6301-768b-9dc5-723154c5f34d)

## **Discussion**

## **More claims by 昂利康**

[**Under normal circumstances, the process takes about 1 to 1.5 years.**prediction](https://dgw.tmarket.io/claims/01a1e5e4-63aa-7a64-afae-37120f4fa436) [**The overall cycle is heavily influenced by the technical route and experimental results.**statement](https://dgw.tmarket.io/claims/01a1e5e4-6396-7fa5-8d4d-8d06cfd7bcd8) [**The production timeline for the self-ionizable lipids will also be tied to 科瑞生物's R&D and production progress.**statement](https://dgw.tmarket.io/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201) [**Going from PCC to IND requires completing candidate molecule confirmation, pharmaceutical and non-clinical research work.**statement](https://dgw.tmarket.io/claims/01a1e5e4-6351-7c14-8459-e9fe818b447f) [**Three pipelines are currently at the preclinical PCC stage and are progressing as planned.**statement](https://dgw.tmarket.io/claims/01a1e5e4-633e-79a8-af50-0f103ce4bd57)

[All claims by 昂利康](https://dgw.tmarket.io/claims?claimant_id=01a1e5e4-6301-768b-9dc5-723154c5f34d)

[All claims](https://dgw.tmarket.io/claims)

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts from 4,500+ Telegram channels — every claim cited. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512#webpage","@type":"WebPage","description":"statement by 昂利康, recorded recently — verbatim quote and source citation.","name":"Based on current experimental data, the targets of the three pipelines are relatively clear and… — 昂利康 — DecisionGateway","url":"https://dgw.tmarket.io/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512","breadcrumb":{"@id":"https://dgw.tmarket.io/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Claims","item":"https://dgw.tmarket.io/claims","position":2},{"@type":"ListItem","name":"Based on current experimental data, the targets of the…","position":3}]},{"@id":"https://dgw.tmarket.io/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512#/schema/quotation/1","@type":"Quotation","dateCreated":"2026-11-11","isBasedOn":"https://t.me/stockintelligencenews/5715383","text":"從目前的實驗數據來看，三條管線靶點相對明確，具備一定成藥的概率","url":"/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512","spokenByCharacter":{"@type":"Person","name":"昂利康","@id":"/actors/01a1e5e4-6301-768b-9dc5-723154c5f34d"}}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.
